Metaoptima
MetaOptima Technology Inc. is a Vancouver-based digital health company founded in 2012 that develops AI-powered dermatology imaging solutions, including the DermEngine analytics platform, OptimaScan 3D total body photography system, and MoleScope mobile dermatoscope, serving dermatologists, healthcare institutions, and patients globally.
- Company typePrivate
- Founded2012
- HeadquartersVancouver, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Metaoptima does
MetaOptima Technology Inc. is a Vancouver-based private digital health and medical device company founded in 2012 by CEO Maryam Sadeghi, PhD and CTO Majid Razmara, PhD. The company develops AI-powered dermatology imaging and analytics solutions spanning the full skin-care workflow from patient self-monitoring to clinical diagnosis. Its three core products are DermEngine, a cloud-based skin imaging and analytics platform with EMR/EHR integration used by dermatologists and medical professionals; OptimaScan, an AI-powered 3D total body photography system with a 360-degree rotating arm, 48MP image capture resolution, and sub-1-minute full-body scan times; and MoleScope, a consumer-grade mobile dermatoscope paired with a smartphone app that enables patients and primary care providers to capture dermoscopic images. The integrated platform combines proprietary computer vision and machine learning algorithms for automated skin disease detection, lesion analysis, and skin cancer screening, with a growing dataset of dermoscopy images serving as a continuous improvement flywheel.
MetaOptima generates revenue through three streams: hardware sales of OptimaScan and MoleScope devices, subscription-based access to the DermEngine platform for medical professionals (sold on annual quote-based contracts), and platform licensing of DermEngine capabilities to healthcare institutions. The go-to-market combines enterprise field sales to hospitals, clinics, and dermatology practices with direct-to-consumer distribution of MoleScope through app stores, supplemented by strong event-driven marketing at major dermatology conferences (MEDICA, EADV, AAD, ATA Nexus, Australasian Skin Cancer Congress, American Dermoscopy Meeting). The company operates through its Canadian parent entity and a wholly-owned Australian subsidiary (MetaOptima Technology Australia Pty Ltd), serving markets in Canada, the United States, Australia, and New Zealand. Recent strategic activity has emphasized Australia and New Zealand expansion through partnerships with the Digital Health & Discovery Platform (DHDP), Skin Check Champions, and Skin Cancer College.
MetaOptima has raised approximately $8.5 million+ in disclosed funding across venture and non-dilutive sources, including a $6.5 million round led by Airtree Ventures and Skip Capital in 2018 and approximately $2.03 million CAD from PacifiCan and Circle Innovation's BC Healthtech SME Program in 2023. The company employs approximately 30 people across engineering, machine learning/AI, sales, regulatory, and operations roles, and has been recognized as an ATA 2024 Nexus Telehealth Innovators Challenge Finalist for DermEngine's AI-powered care coordination.
Metaoptima firmographics
Firmographics- Name
- Metaoptima
- Legal name
- MetaOptima Technology Inc.
- Website
- https://metaoptima.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MetaOptima Technology Inc. is a Vancouver-based digital health company founded in 2012 that develops AI-powered dermatology imaging solutions, including the DermEngine analytics platform, OptimaScan 3D total body photography system, and MoleScope mobile dermatoscope, serving dermatologists, healthcare institutions, and patients globally.
- Ownership category
- akta.pro rank
Metaoptima industry classification
Industry- Product category
- Dermatology Imaging & Analytics Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industry
- Dermatology Telemedicine Platforms (HLALAGAA)
Keywords
Where Metaoptima is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Metaoptima business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Hardware Sales: Sale of OptimaScan and MoleScope imaging devices to healthcare providers and patients
- Software Subscriptions: Subscription-based access to DermEngine platform for medical professionals with tiered features for imaging, analytics, and EMR/EHR integration
- Platform Licensing: Licensing of DermEngine platform capabilities to healthcare institutions and partners for integration into their workflows
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise healthcare institution pricing |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Metaoptima product offering
Product offeringCore offering
MetaOptima develops and sells AI-powered dermatology imaging and analytics solutions built around three integrated products: DermEngine, a cloud-based platform for skin imaging, AI-assisted analysis, and EMR/EHR-integrated documentation used by medical professionals; OptimaScan, an AI-powered 3D total body photography system with 360° rotating arm and 48MP capture; and MoleScope, a smartphone-connected dermatoscope and app for patient skin monitoring and tele-dermatology.
Product overview
MetaOptima offers an integrated multi-product platform for intelligent dermatology consisting of three core products: OptimaScan (AI-powered 3D total body photography device with 48MP resolution), DermEngine (cloud-based skin imaging and analytics platform for medical professionals), and MoleScope (mobile dermatoscope and app for patients). These products work together as an ecosystem where OptimaScan and MoleScope capture skin images which are then analyzed by DermEngine's AI-powered analytics platform for skin disease detection and management.
Differentiator
Problem solved
Functional benefit
Brands
- OptimaScan: AI-Powered 3D Total Body Photography system with 360° rotating arm, 48MP capture, and seamless DermEngine integration for full-body imaging in under 1 minute.
- DermEngine
- MoleScope
Products and services
- OptimaScan AI-Powered 3D Total Body Photography hardware system with a 360° rotating arm, 48MP image capture, and scan time under 1 minute, designed for clinical full-body skin imaging with seamless DermEngine integration for AI-powered skin analysis. Targeted at healthcare institutions, hospitals, and dermatology practices.
- DermEngine Cloud-based platform for skin imaging, AI-powered skin analysis, and clinical documentation with EMR/EHR integration. Provides intelligent dermatology workflows, lesion analysis, teledermatology, and AI-powered care coordination for medical professionals and healthcare institutions.
- MoleScope Affordable smartphone-connected dermatoscope device and companion mobile app that enables patients and consumers to capture dermoscopic images for personal skin monitoring, mole tracking, and tele-dermatology consultations with healthcare providers.
Quantifiable outcome
- Full-body imaging in under 1 minute with 360° rotation and 48MP capture resolution
- +2 more outcomes
Companies that use Metaoptima
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Metaoptima technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature4 records
Metaoptima partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Digital Health & Discovery Platform (DHDP)corePartnership to expand access to skin cancer detection in Australia, bringing advanced skin checks to communities outside major cities using OptimaScan's mobile 3D Total Body Photography system.
- Skin Cancer College (New Zealand)minorHosted exclusive roundtable event at New Zealand Parliament where ministers and officials received professional skin checks using DermEngine as part of skin cancer awareness activities.
- Skin Check ChampionscorePioneering the world's first targeted, AI-assisted and nurse-led skin check program in Australia. MetaOptima provides DermEngine and OptimaScan technology to enable community-based skin cancer screening for underserved populations in Australia.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Metaoptima competitors and assessment
Company assessmentDirect peers
- Skin Analytics: UK-based AI dermatology company focused on skin cancer detection with regulatory-cleared deep learning models used in NHS pathways. Direct comparable in AI-powered skin lesion triage and clinical dermatology workflows.
- SkinVision: Amsterdam-based company offering a smartphone app for AI-powered skin cancer risk assessment with consumer and clinician-facing tiers. Closely comparable to MoleScope plus DermEngine as an integrated consumer/professional dermatology AI platform.
- DermaSensor: US-based developer of a handheld, FDA-cleared AI-powered spectroscopy device for primary-care skin cancer detection. Directly comparable as a hardware-plus-AI dermatology diagnostic aimed at non-dermatologist clinicians.
- FotoFinder Systems: German manufacturer of total body photography and AI-assisted dermoscopy systems widely used by dermatologists. Direct competitor to OptimaScan in the enterprise 3D body imaging hardware segment.
- MoleMap: Australia and New Zealand skin cancer screening service combining dermoscopy, dermatologist review, and longitudinal mole monitoring. Operates in the same APAC geographies as MetaOptima's Australian and NZ deployments.
- First Derm: Teledermatology platform offering asynchronous dermatologist consultations via a smartphone app. Comparable to the consumer MoleScope + DermEngine teledermatology workflow.
Broad incumbents
- Canfield Scientific: Established US-based provider of medical imaging systems for dermatology, aesthetics, and plastic surgery with broad hardware/software portfolios. Comparable to MetaOptima's OptimaScan plus DermEngine for dermatology practices, but at much larger scale and broader scope.
- Google Health (DermAssist): Google's AI dermatology assistant offering condition-matching from smartphone photos, integrated with Search. Functions as a broad incumbent that competes for the same clinical decision-support and patient-facing dermatology AI workflows as DermEngine and MoleScope.
Emerging players
- Skinive: EU-based AI dermatology app providing skin condition and risk assessment via smartphone, with a clinician-facing API. Comparable to MoleScope as a consumer/clinical skin analysis tool, with overlapping teledermatology applications.
- 3Derm Systems: US-based teledermatology hardware and software provider for primary care and remote skin triage. Comparable as a combined imaging-device-plus-platform solution aimed at non-dermatologist clinicians, similar to MetaOptima's enterprise positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Metaoptima social profiles
Digital presenceMetaoptima financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metaoptima leadership team
Management profileNumber of profiles
Profiles1 record
Metaoptima subsidiaries and ownership
Company hierarchySubsidiaries1 record
Metaoptima funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metaoptima M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metaoptima
What does Metaoptima do?
MetaOptima develops and sells AI-powered dermatology imaging and analytics solutions built around three integrated products: DermEngine, a cloud-based platform for skin imaging, AI-assisted analysis, and EMR/EHR-integrated documentation used by medical professionals; OptimaScan, an AI-powered 3D total body photography system with 360° rotating arm and 48MP capture; and MoleScope, a smartphone-connected dermatoscope and app for patient skin monitoring and tele-dermatology.
Is Metaoptima a public or private company?
Metaoptima is a private company. It is classified as venture growth investor backed and is currently operating.
When was Metaoptima founded?
Metaoptima was founded in 2012. It employs 11 to 50 people.
Where is Metaoptima based?
Metaoptima is headquartered in Vancouver, Canada, in the North America region.
How does Metaoptima make money?
Three revenue lines are on record. Hardware Sales are the primary driver. The others are software Subscriptions and platform Licensing.
Who are Metaoptima's main competitors?
Direct peers on record are Skin Analytics, SkinVision, DermaSensor, FotoFinder Systems, MoleMap and First Derm. Broad incumbents are Canfield Scientific and Google Health (DermAssist). Emerging players are Skinive and 3Derm Systems.
Does Metaoptima have an API?
No public API is recorded for Metaoptima.
What industry is Metaoptima in?
Metaoptima's product category is Dermatology Imaging & Analytics Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLALAGAA, Dermatology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3841.